Anti-progesterone treatment using specific anti \x=req-\ progesterone antibodies or a progesterone receptor (PR) antagonist during first pregnancy impairs postpartum maternal behaviour in mice. This effect is demonstrable only if the treatment is given during pregnancy but not immediately after parturition. 
antagonist during first pregnancy impairs postpartum maternal behaviour in mice. This effect is demonstrable only if the treatment is given during pregnancy but not immediately after parturition. The purpose of the present studies was to investigate if maternal behaviour is also impaired by anti-progesterone treatment in subsequent pregnancies.
Studies with a monoclonal antibody to progesterone (DB3; 4\m=.\5 nmol/mouse) showed that injection of females on day 17 of second pregnancy did not cause maternal rejection but the latency of pup retrieval was prolonged especially during the first 3 days of lactation. This phenomenon was not observed in animals that had previous experience of full length lactation. Experiments were carried out with mifepristone (RU486; 10 \g=m\g/mouse) injected at day 17 of first, second or third pregnancies. Pup rejection (22\m=.\5% vs 12\m=.\3%) and prolongation of the retrieval latency (62\m=.\3 \m=+-\ 1 3 \ m=. \ 3 vs 19\m=.\7\m=+-\ 6\ m=. \ 5 s; P<0\m=.\02) were observed following the first pregnancy. No abnormal behavioural effects were found in mothers treated in second or third pregnancy who had prior full length lactation experience. Control females subjected to only one pup retrieval test after first delivery rejected their pups if treated in their second pregnancy (27.3% vs 4\m=.\4%; P<0\m=.\001) and displayed a marginal prolongation of the retrieval latency period (20\m=.\9 \m=+-\ 7\ m=. \ 0 vs 7\m=.\4 \ m=+-\ 2\m=.\6 s). Anti \x=req-\ progesterone treatment had no negative influence when administered during third pregnancy.
To determine whether treatment with RU486
(50 \g=m\g/mouse,day 17) (Wang et al. 1992 (Wang et al. , 1995 .
Very similar results have been obtained with mifepris¬ tone (RU486) indicating that this progesterone receptor (PR) antagonist also interferes with the hormonal priming mechanism(s) necessary for the onset of normal maternal behaviour. The commonality of findings with a PR antagonist as well as antibody scavenging of progesterone point to a central effect that is receptor-mediated, progesterone-dependent, and normally essential for the priming of maternal recognition and care of pups (Wang et al. 19956) .
The importance of progesterone among the mechanisms that establish the rapid onset of maternal behaviour after Progesterone receptor antagonist Mifepristone (RU486; gift from Roussel-Uclaf, Romainville, France), dissolved in sesame oil, was administered as a single dose (10 µg or 50 µg per animal) subcutaneously (s.c.) into pregnant (day 17) mice (para 1, para 2a, para 2b and para 3). Control animals received an equivalent volume ofsesame oil (0 ml). For para 1 females treated with 50 µg RU486, no treatment was given during the second pregnancy (para 2b).
Postpartum behaviour test
The behavioural methods employed in this study were based on those commonly used in the mouse (Noirot 1965) and rat (Rosenblatt 1967 , Orpen et al. 1987 , and were similar to our previously reported procedure (Wang et al. 1992 (Wang et al. , 1995a 
Results
Effect ofpassive immunization Anti-progesterone antibody (DB3) passively transferred on day 17 of first gestation (para 1) had no effect on the length of pregnancy but a pronounced influence on subsequent maternal behaviour. Almost 50% of the pups were rejected by para I mothers. This was fourfold greater than the incidence of rejection in the control group. Rejection was mainly in the form of cannibalism and failure to nurse. The number of pups born and their weight at weaning were not significantly different between treated and control groups (Table 1) .
In para 2a and para 3 females, passive immunization on day 17 of gestation had no effect on subsequent maternal care (Table 1) , but latency to the first retrieval of pups was significantly prolonged in treated dams (para 2d) compared with the control group (21-7 ± 5-2 vs 9-3 ± 4-4 s; <0·05).
Effect ofRU486 treatment Administration of RU486 (10 µg/mouse s.c.) on day 17 of first gestation (para 1) had no effect on the length of gestation but subsequent maternal rejection of pups was almost doubled compared with controls. In para 2b and para 3, maternal rejection was low and even less than that in control females ( Table 2 ). The number of pups born and their weight at weaning were not significantly different between treated and control groups (Table 2) . However, those born to para í-treated females were apparently fewer in number than in any other group probably because of cannibalism immediately after delivery which would not have been observed using the present protocol.
In order to determine if a full lactation period is necessary to overcome RU486-induced maternal rejec¬ tion, a single pup retrieval test was performed on para 1 females immediately after delivery. Pups were then re¬ moved permanently so that lactation was curtailed. After treatment with RU486 during second pregnancy, mater¬ nal rejection of pups was still much greater (6-fold) than in control females (para 2a, Table 2 ).
Carryover effect from one pregnancy to another 20-7 ± 0-2 8-5 ± 0-8 reduced and less frequently observed than in control animals ( 
